Fate Therapeutics
FATE
FATE
202 hedge funds and large institutions have $2.95B invested in Fate Therapeutics in 2020 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 73 increasing their positions, 50 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
7% less call options, than puts
Call options by funds: $7.17M | Put options by funds: $7.7M
1.67% less ownership
Funds ownership: 104.15% → 102.47% (-1.7%)
Holders
202
Holding in Top 10
7
Calls
$7.17M
Puts
$7.7M
Top Buyers
| 1 | +$116M | |
| 2 | +$63.4M | |
| 3 | +$48.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$34.6M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$25.1M |
Top Sellers
| 1 | -$150M | |
| 2 | -$59.1M | |
| 3 | -$24.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.7M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$13.5M |